Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Antiretroviral Pharmacovigilance'

Antiretroviral Pharmacovigilance published presentations and documents on DocSlides.

Toolkit for research and development of paediatric antiretroviral drugs and formulations

Toolkit for research and development of paediatric antiretroviral drugs and formulations

  • luanne-stotts
  • 0 Slides

Module 10:. Pharmacovigilance. Background – def...

Social Pharmacy and Pharmacovigilance

Social Pharmacy and Pharmacovigilance

  • debby-jeon
  • 0 Slides

JAMASOFT2017. 1. Social. Pharmacy. Pharmacoepide...

Pharmacovigilance 1 Dr. Ganesh Uchit

Pharmacovigilance 1 Dr. Ganesh Uchit

  • liane-varnes
  • 0 Slides

, MD. Pfizer, India. DISCLAIMER. Overview. Intr...

Pharmacovigilance: challenges facing WHO

Pharmacovigilance: challenges facing WHO

  • celsa-spraggs
  • 0 Slides

Shanthi Pal. Leader, Medicines Safety. Safety . a...

Introduction to pharmacovigilance

Introduction to pharmacovigilance

  • ellena-manuel
  • 0 Slides

Monitoring the safety of medicines. Pharmacovigil...

Pharmacovigilance: challenges facing WHO

Pharmacovigilance: challenges facing WHO

  • debby-jeon
  • 0 Slides

Shanthi Pal. Leader, Medicines Safety. Safety . a...

Intensive Enfuvirtide -containing Antiretroviral Therapy

Intensive Enfuvirtide -containing Antiretroviral Therapy

  • bety
  • 7 Slides

A5173 Study. Intensive . Enfuvirtide. -containing ...

New Antiretroviral Drugs in Development and Novel ART Regimens

New Antiretroviral Drugs in Development and Novel ART Regimens

  • paisley
  • 4 Slides

Constance A. Benson, MD. Professor of Medicine and...

Pharmacovigilance:

Pharmacovigilance:

  • lois-ondreau
  • 23 Slides

New challenges for WHO. Dr Shanthi Pal. . Group ...

Post Market Surveillance

Post Market Surveillance

  • alida-meadow
  • 30 Slides

KNH/UON . Pharmacy Symposium. Optimizing Medicine...

Pharmacovigilance:

Pharmacovigilance:

  • kittie-lecroy
  • 16 Slides

New challenges for WHO. Dr Shanthi Pal. . Group ...

Pharmacovigilance: New challenges for WHO

Pharmacovigilance: New challenges for WHO

  • pamella-moone
  • 0 Slides

Dr Shanthi Pal. . Group Lead, Medicines Safety ....

Introduction to Pharmacovigilance

Introduction to Pharmacovigilance

  • lindy-dunigan
  • 0 Slides

& . Adverse Drug Reactions . Reporting system...

Prospects and Challenges of Providing

Prospects and Challenges of Providing

  • mitsue-stanley
  • 24 Slides

Prospects and Challenges of Providing Pharmacovi...

Prospects and Challenges of Providing

Prospects and Challenges of Providing

  • mitsue-stanley
  • 24 Slides

Prospects and Challenges of Providing Pharmacovi...

Country Experience in Monitoring New

Country Experience in Monitoring New

  • fauna
  • 12 Slides

ARVs: Focus on Toxicity Monitoring . and Surveill...

Clin Pract

Clin Pract

  • blanko
  • 12 Slides

1466 Nikhil GuptaKavita BahmaniAjit Jangra Introdu...

Principles of Risk Management

Principles of Risk Management

  • desha
  • 13 Slides

No medicine is without . risk and the.  . benefi...

Vaccine Pharmacovigilance

Vaccine Pharmacovigilance

  • mia
  • 21 Slides

Definition- . According to the CIOMS/WHO working g...

Pharmacovigilance and drug safety trainings to increase Tuberculosis (TB) preventive treatment (TPT

Pharmacovigilance and drug safety trainings to increase Tuberculosis (TB) preventive treatment (TPT

  • karsyn769
  • 3 Slides

Authors: . 1. Juliet Jokwiro, . 1. Nicole Chekuda...

Aspects of pharmacovigilance: Public hearings

Aspects of pharmacovigilance: Public hearings

  • sean858
  • 10 Slides

A public hearing is a forum to which the public is...

Adherence Monitoring in HIV Care

Adherence Monitoring in HIV Care

  • tatiana-dople
  • 0 Slides

Simi Padival, MD. November 3, 2016. Objectives. L...

Public Health Surveillance of Transmitted Antiretroviral Resistance, Oregon 2007 – 2011

Public Health Surveillance of Transmitted Antiretroviral Resistance, Oregon 2007 – 2011

  • tatiana-dople
  • 0 Slides

Sean Schafer MD. May 31, 2012. Three Studies in O...

HIV Pharmacotherapy Focused Update

HIV Pharmacotherapy Focused Update

  • sherrill-nordquist
  • 0 Slides

Drew Lambert, . PharmD. lambertd@husson.edu. Huss...

Phylodynamically Estimated HIV Diversification Rates Reveal Prevention of HIV-1 by Antiretroviral T

Phylodynamically Estimated HIV Diversification Rates Reveal Prevention of HIV-1 by Antiretroviral T

  • sherrill-nordquist
  • 0 Slides

Jeffrey B. Joy, Richard H. Liang, Rosemary M. McC...

د. حسين محمد جمعه

د. حسين محمد جمعه

  • alexa-scheidler
  • 0 Slides

اختصاصي الامراض الباطنة . ا...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

  • phoebe-click
  • 0 Slides

ACTIVITY CODE . TD342. Antiretroviral Medications...

Recommendations for the Use of Antiretroviral Drugs in Pregnant Women

Recommendations for the Use of Antiretroviral Drugs in Pregnant Women

  • ash
  • 4 Slides

G-103 Ckbeceopap (Pubkop( CO>E) (Last updated Dece...

Periconceptional Antiretroviral Exposure and Central Nervous System and Neural Tube Defects – D

Periconceptional Antiretroviral Exposure and Central Nervous System and Neural Tube Defects – D

  • norah
  • 23 Slides

Antiretroviral Pregnancy Registry. LM Mofenson, V ...

Vitamin D and HIV Subbulaxmi

Vitamin D and HIV Subbulaxmi

  • bitsy
  • 18 Slides

. Trikudanathan. , MD, MRCP, . MMSc. Division of E...

x0000x0000Recommendations for the Use of Antiretroviral Drugs Du

x0000x0000Recommendations for the Use of Antiretroviral Drugs Du

  • brown
  • 8 Slides

(Last updated December 30, 2021; last reviewed Dec...

Effects of first -line antiretroviral

Effects of first -line antiretroviral

  • esther
  • 15 Slides

therapy. . on. . the. CD4/CD8 ratio and CD8 . ce...

September EMA Inspections and Human Medicines Pharmacovigilance D ivision Questions answers on signal management This document addresses a number of questions which stakeholders in particular marke

September EMA Inspections and Human Medicines Pharmacovigilance D ivision Questions answers on signal management This document addresses a number of questions which stakeholders in particular marke

  • alida-meadow
  • 10 Slides

If you have a question on signal managem ent that...

JanuaryEMA/118465/2012Guideline on good pharmacovigilance practice(GVP

JanuaryEMA/118465/2012Guideline on good pharmacovigilance practice(GVP

  • faustina-dinatale
  • 100 Slides

Draft agreed by ERMS FG20 July 2012 Draft adopted ...

Guideline on good pharmacovigilance practices (GVP)Module II Pharmacov

Guideline on good pharmacovigilance practices (GVP)Module II Pharmacov

  • pasty-toler
  • 100 Slides

9 April EMA/816573/2011Rev 1* Draft agreed by ERM...

Off-label Use Off-label use of medicines is

Off-label Use Off-label use of medicines is

  • karlyn-bohler
  • 0 Slides

NOT. regulated by EU legislation and no uniform ...

8 September 2014EMA//2011Rev 1*Guideline on good pharmacovigilance pra

8 September 2014EMA//2011Rev 1*Guideline on good pharmacovigilance pra

  • giovanna-bartolotta
  • 100 Slides

Draft Revision 1 agreed by ERMS FG29 May 2013 Draf...

The GVS blueprint and its implementation

The GVS blueprint and its implementation

  • alexa-scheidler
  • 28 Slides

. Dr Madhava Ram. Medical Officer. EMP/ SAV. Uns...

About OMICS Group OMICS Group is an amalgamation of

About OMICS Group OMICS Group is an amalgamation of

  • phoebe-click
  • 0 Slides

Open Access Publications. and worldwide internat...

Benefits of a strong collaboration with patient groups

Benefits of a strong collaboration with patient groups

  • min-jolicoeur
  • 0 Slides

at national . and EU level. Susanna Palkonen, Dir...

Copyright © 2024 DocSlides. All Rights Reserved